Cargando…
Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature
Background: Despite many studies, it is still unclear how patients with neuromyelitis optica spectrum disorder (NMOSD) would respond to coronavirus disease 2019 (COVID-19). We conducted a research on prevalence of COVID-19 in patients with NMOSD in Isfahan, Iran. We have also reviewed the recent pub...
Autores principales: | Etemadifar, Masoud, Salari, Mehri, Aminzade, Zahra, Ebrahimi, Sara, Tehrani-Fateh, Sepand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984777/ http://dx.doi.org/10.18502/cjn.v20i3.7689 |
Ejemplares similares
-
Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality
por: Salari, Mehri, et al.
Publicado: (2022) -
Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
por: Salari, Mehri, et al.
Publicado: (2021) -
Case series: New‐onset freezing of gait in combined use of deep brain stimulation and Levodopa
por: Salari, Mehri, et al.
Publicado: (2021) -
Neuromyelitis optica spectrum disorder in a patient with ankylosing spondylitis: A case report
por: Salari, Mehri, et al.
Publicado: (2023) -
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
por: Etemadifar, Masoud, et al.
Publicado: (2017)